TCRR Market Cap History



Below is a table of the TCRR market cap history going back to 2/14/2019:

Date TCRR Market Cap
2/14/2019349.47M
3/25/2019400.99M
5/6/2019385.67M
7/30/2019377.21M
8/6/2019273.48M
10/31/2019298.74M
3/21/2020165.88M
5/3/2021857.51M
8/2/2021490.65M
11/2/2021257.99M
3/18/2022106.00M
5/2/202289.04M
8/1/2022116.98M
11/1/202259.15M
3/5/202347.49M
5/1/202372.24M

Also see: TCRR Shares Outstanding History
and TCRR YTD Return
TCRR Historical Market Cap:
-31.24% CAGR
TCRR Historical Market Cap: +-31.24% CAGR

Mouse over chart for data details
2/14/2019 ...5/1/2023
TCR2 Therapeutics is a clinical-stage cell therapy company developing T cell therapies for cancer patients suffering from solid tumors by powering the T cell receptor (TCR) with its TCR Fusion Construct T cells (TRuC-T cells). Co.'s TRuC-T cells recognize and kill cancer cells by using the entire TCR signaling complex. Co.'s TRuC-T cell targeting mesothelin-expressing solid tumors are: gavocabtagene autoleucel, in which Co. is conducting its clinical trial to treat patients with non-small cell lung cancer, ovarian cancer, malignant pleural/peritoneal mesothelioma or cholangiocarcinoma; and TC-510, which incorporates a PD-1:CD28 chimeric switch receptor. We show 16 historical shares outstanding datapoints in our TCRR shares outstanding history coverage, used to compute TCRR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TCRR market cap history over the course of time is important for investors interested in comparing TCRR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TCRR versus a peer is one thing; comparing TCRR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TCRR can fluctuate over the course of history. With this page we aim to empower investors researching TCRR by allowing them to research the TCRR market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree TCRR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
TCR2 Therapeutics (TCRR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

TCRT Market Cap History
TCRX Market Cap History
TDOC Market Cap History
TECH Market Cap History
TELA Market Cap History
TENX Market Cap History
TERN Market Cap History
TEVA Market Cap History
TFFP Market Cap History
TFX Market Cap History
More Healthcare companies »

 

TCRR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.